Skip to main content
SpringerLink
Log in

PHYSIOLOGY: A Rise of the Serum Level of von Willebrand Factor Occurs Before Clinical Manifestation of the Severe Form of Ovarian Hyperstimulation Syndrome

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Background: Ovarian hyperstimulation syndrome (OHSS) appears to be caused by increased capillary permeability in the vascular endothelial cells. Such cells secrete excess amounts of von Willebrand factor (vWF), a large adhesive glycoprotein.

Methods: We retrospectively evaluated the circulating levels of vWF and of vascular endothelial growth factor (VEGF) twice, on the days of oocyte retrieval and embryo transfer, in 46 women who developed early-onset OHSS.

Results: Nineteen, 14, and 13 women developed mild, moderate, and severe OHSS, respectively. Inconsistent changes were observed in the VEGF during oocyte retrieval and embryo transfer. However, the net increase in serum vWF during that period showed an increase in absolute value at the time of embryo transfer that paralleled an increase in the severity of OHSS. That is, in mild OHSS, the serum vWF increased from 140 ± 44 to 164 ± 28%; in moderate OHSS, it increased from 113 ± 47 to 186 ± 22± and in severe OHSS, it increased from 120 ± 35 to 274 ± 63%. All 9 women with a vWF level >230% at embryo transfer developed severe OHSS, while 9 of 13 women with severe OHSS exhibited a vWF >230% at embryo transfer.

Conclusion: The results suggest that a rise of the serum level of vWF occurs prior to clinical manifestation of OHSS in patients with severe OHSS but not in patients with mild OHSS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Schenker JG, Weinstein D: Ovarian hyperstimulation syndrome: A current survey. Fertil. Steril 1978;30:255-260

    Google Scholar 

  2. Editorial: Ovarian hyperstimulation syndrome. Lancet 1991;338:1111-1112

    Google Scholar 

  3. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth J: Risk factors and prognostic variables in the ovarian hyper-stimulation syndrome. Am J Obstet Gynecol 1988;159:210-215

    Google Scholar 

  4. Amso NN, Ahuja KK, Morris N, Shaw RW: The management of predicted ovarian hyperstimulation involving gonadotropinreleasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril 1990;53:1087-1090

    Google Scholar 

  5. Tollan A, Holst N, Forsdahl, F, Fadnes HO, Oian P, Maltau JM: Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization. Am J Obstet Gynecol 1990;162:554-558

    Google Scholar 

  6. Mordel N, Schenker JG: Gonadotrophin releasing hormone agonist and ovarian hyperstimulation syndrome in assisted reproduction. Hum Reprod 1993;8:2009-2014

    Google Scholar 

  7. Schenker JG: Prevention and treatment of ovarian hyperstimulation syndrome. Hum Reprod 1993;8:653-659

    Google Scholar 

  8. Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch RH: Increased capillary permeability induced by human follicular fluid:Ahypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril 1995;63:268-272

    Google Scholar 

  9. Tsirigotis M, Craft I: Ovarian hyperstimulation syndrome (OHSS): How much do we really know about it? Eur J Obstet Gynecol 1994;55:151-155

    Google Scholar 

  10. Adashi EY: The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocr Rev 1990;11:454-464

    Google Scholar 

  11. Ong AC, EisenV, Rennie DP, Homburg R, Lachelin GC, Jacobs HS, Slater JD: The pathogenesis of the ovarian hyperstimulation syndrome (OHSS): A possible role for ovarian renin. Clin Endocrinol 1991;34:43-49

    Google Scholar 

  12. Friedlander MA, Loret de Mola JR, Goldfarb JM: Elevated level of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 1993;60:826-833

    Google Scholar 

  13. Kamada S, Kubota T, Taguchi M, Aso T: High levels of immunoreactive endothelin-1 in human follicular fluids.HumReprod 1993;8:674-677

    Google Scholar 

  14. Delbaere A, Bergmann PJ, Gervy-Decoster C, Staroukine M, Englert Y: Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: Implications for pathophysiology and clinical management. Fertil Steril 1994;62:731-737

    Google Scholar 

  15. Orvieto R, Ben-Rafael Z: Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod 1998;13:3306-3309

    Google Scholar 

  16. Abramov Y, Barak V, Nisman B, Schenker JG: Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997;67:261-265

    Google Scholar 

  17. Bermann F, Rotmensch S, Rosenzweig B, How H, Chediak J: The role of von Willebrand factor in pre-eclampsia. Thromb Haemost 1991;66:525-528

    Google Scholar 

  18. Rodgers GM, Taylor RN, Roberts JM: Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1998;159:908-914

    Google Scholar 

  19. Todorow S, Schricker ST, Siebzehnruebl ER, Neidhardt B, Wildt L, Lang N: vonWillebrand factor: An endothelial maker to monitor in vitro fertilization patients with ovarian hyperstimulation syndrome. Hum Reprod 1993;8:2039-2046

    Google Scholar 

  20. Pittet JL, Barbalat V, Sanvert M, Villard C, Jorieux S, Mazurier C: Evaluation of a new automated ELISA test for vonWillebrand factor using two monoclonal antibodies. Blood Coagulat Fibrinolysis 1997;8:209-215

    Google Scholar 

  21. Handin RI, Wagner DD: Molecular and cellular biology of von Willebrand factor. Prog Hemost Thromb 1989;9:233-259

    Google Scholar 

  22. Ginsburg D: The von Willebrand factor gene and genetics of vonWillebrand's disease. Proc Mayo Clin 1991;66:506-515

    Google Scholar 

  23. Moake JL, Rudy CK: Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenia purpura. N Engl J Med 1982;307:1432-1433

    Google Scholar 

  24. Bloom AL: Von Willebr and factor: Clinical features of inherited and acquired disorders. Proc Mayo Clin 1991;66:743-751

    Google Scholar 

  25. McClure N, Healy DL, Rogers PA, Sullivan J, Hanging RV, ConnollyDT, Robertson DM: Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235-236

    Google Scholar 

  26. Morris RS, Paulson RJ: Ovarian derived prorenin angiotensin cascade in human reproduction. Fertil Steril 1994;62:1105-1114

    Google Scholar 

  27. Ravel A, Barak V, Lavy Y, Anteby E, Abramov Y, Schenker JJ, Amit A, Finci-Yeheskel Z, Mayer M, Simon A, Laufer N, Hurwitz A: Characterization of intraperitoneal cytokines and nitrites in women with severe OHSS-A multicenter study. Fertil Steril 1996;66:66-71

    Google Scholar 

  28. Yan Z, Weich HA, Bernart W, Breckwoldt M, Neulen J: Vascular endothelial growth factor (VEGF) messenger ribonucleic acid expression in luteinized human granulosa cells in vitro. Endocrinology 1993;77:1723-1725

    Google Scholar 

  29. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1993;219:983-985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Jichi Medical School, Minamikawachi-machi, Tochigi, 329-0498, Japan

    Shuichi Ogawa, Hisanori Minakami, Shigeo Araki, Takashi Ohno, Hiroaki Shibahara & Ikuo Sato

  2. Central Clinic, Minamikawachi-machi, Tochigi, 329-0498, Japan

    Mitsuhiro Motoyama

Authors
  1. Shuichi Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisanori Minakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shigeo Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Ohno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mitsuhiro Motoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroaki Shibahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ikuo Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogawa, S., Minakami, H., Araki, S. et al. PHYSIOLOGY: A Rise of the Serum Level of von Willebrand Factor Occurs Before Clinical Manifestation of the Severe Form of Ovarian Hyperstimulation Syndrome. J Assist Reprod Genet 18, 114–119 (2001). https://doi.org/10.1023/A:1026590910462

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026590910462

Search

Navigation